Virtus ETF Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History

Virtus ETF Advisers’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$957K	Hold	42,974	–	–	0.44%	45
2025 Q4	$1.15M	Hold	42,974	–	–	0.54%	38
2025 Q3	$917K	Hold	42,974	–	–	0.51%	50
2025 Q2	$927K	Hold	42,974	–	–	0.57%	40
2025 Q1	$714K	Buy	42,974 +22,716	+112%	+$413K	0.46%	56
2024 Q4	$372K	Sell	20,258 -1,568	-7%	-$25.3K	0.15%	192
2024 Q3	$336K	Hold	21,826	–	–	0.16%	220
2024 Q2	$355K	Buy	21,826 +8,247	+61%	+$133K	0.17%	193
2024 Q1	$251K	Buy	13,579 +1,954	+17%	+$48.4K	0.13%	232
2023 Q4	$364K	Sell	11,625 -980	-8%	-$23.4K	0.23%	181
2023 Q3	$263K	Sell	12,605 -1,630	-11%	-$44.3K	0.16%	219
2023 Q2	$341K	Sell	14,235 -5,285	-27%	-$117K	0.2%	166
2023 Q1	$367K	Buy	19,520 +347	+2%	+$6.61K	0.2%	159
2022 Q4	$305K	Buy	19,173 +4,680	+32%	+$73.2K	0.16%	257
2022 Q3	$237K	Buy	14,493 +213	+1%	+$3.45K	0.09%	296
2022 Q2	$201K	Sell	14,280 -1,892	-12%	-$35.3K	0.07%	312
2022 Q1	$392K	Hold	16,172	–	–	0.18%	153
2021 Q4	$377K	Sell	16,172 -613	-4%	-$12.3K	0.14%	172
2021 Q3	$279K	Sell	16,785 -1,545	-8%	-$29.8K	0.12%	207
2021 Q2	$447K	Buy	18,330 +6,326	+53%	+$143K	0.18%	183
2021 Q1	$310K	Buy	12,004 +329	+3%	+$14.5K	0.13%	237
2020 Q4	$624K	Sell	11,675 -1,073	-8%	-$53.3K	0.26%	100
2020 Q3	$526K	Buy	12,748 +1,074	+9%	+$46.4K	0.28%	128
2020 Q2	$566K	Sell	11,674 -1,602	-12%	-$76.9K	0.27%	129
2020 Q1	$561K	Sell	13,276 -1,120	-8%	-$46.1K	0.23%	162
2019 Q4	$616K	Sell	14,396 -14,167	-50%	-$616K	0.1%	185
2019 Q3	$1.03M	Sell	28,563 -4,804	-14%	-$146K	0.21%	149
2019 Q2	$892K	Buy	+33,367	New	+$852K	0.19%	156
2016 Q4	–	Sell	-15,878	Closed	-$505K	–	176
2016 Q3	$505K	Buy	15,878 +2,001	+14%	+$67.8K	0.24%	72
2016 Q2	$450K	Buy	13,877 +6,520	+89%	+$218K	0.33%	64
2016 Q1	$206K	Sell	7,357 -457	-6%	-$9.96K	0.28%	78
2015 Q4	$279K	Buy	+7,814	New	+$275K	0.87%	46